Anuradha Guthikonda, M.D

34% fewer Medicare Part D claims than the average endocrinology, diabetes & metabolism physician in 2024

1,747 Medicare Part D claims for 304 beneficiaries, against an average of 2,630 among the 8,223 providers of this specialty who prescribed in Part D. Brand-name drugs were 60% of claims.

Most prescribed

1. Levothyroxine Sodium184 claims
2. Metformin Hcl Er144 claims
3. Lantus Solostar112 claims
4. Ozempic100 claims
5. Jardiance87 claims
6. Farxiga74 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 98.5 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $272.60

13 payments; by number, the most common kind was food and beverage; the largest payer was Lilly USA, LLC. The 5,661 providers of this specialty with any payment received $5,742.15 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

One hospital affiliation

1. Cgh Medical CenterSterling, IL · Acute Care Hospitals1 of 5 stars

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through); hospitals matched to CMS Hospital General Information (Care Compare) (data.cms.gov). Star ratings are CMS hospital ratings, not ratings of this provider.